FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mitchell Creinin

Research Profile

Chemicals & Drugs

Physiology

Concepts & Ideas

Procedures

Living Beings

Young Adult

Devices

Female Contraceptive Devices

Co-author Network

Publications

TOP 3
Johannes Bitzer; Teresa Bombas; Mitchell Creinin; Philip D Darney; Kristina Gemzell Danielsson; Bruno Imthurn; Jeffrey T Jensen; Andrew M Kaunitz; Ali Kubba; Medard M Lech; Diana Mansour; Gabriele Merki; Thomas Rabe; Katarina Sedlecki; David Serfaty; Jacques Seydoux; Lee P Shulman; Regine Sitruk-Ware; Sven O Skouby; Anne Szarewski; James Trussell; Lisa Ferreira Vicente; Jean-Jacques Amy; Rob Beerthuizen; Martin Birkhäuser; Carolyn Westhoff
Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism.
Heather L Hohmann; Lisa K Perriera; Matthew Reeves; Beatrice A Chen; Jennifer L Hayes; Mitchell Creinin
Immediate versus delayed insertion of the levonorgestrel-releasing intrauterine device following dilation and evacuation: a randomized controlled trial.
Leah C Wilson; Leslie A Meyn; Mitchell Creinin
Cervical preparation for surgical abortion between 12 and 18 weeks of gestation using vaginal misoprostol and Dilapan-S.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mitchell Creinin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Johannes Bitzer; Teresa Bombas; Mitchell Creinin; Philip D Darney; Kristina Gemzell Danielsson; Bruno Imthurn; Jeffrey T Jensen; Andrew M Kaunitz; Ali Kubba; Medard M Lech; Diana Mansour; Gabriele Merki; Thomas Rabe; Katarina Sedlecki; David Serfaty; Jacques Seydoux; Lee P Shulman; Regine Sitruk-Ware; Sven O Skouby; Anne Szarewski; James Trussell; Lisa Ferreira Vicente; Jean-Jacques Amy; Rob Beerthuizen; Martin Birkhäuser; Carolyn Westhoff
Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism.
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception 2013;18(3):143-7.
2012: Heather L Hohmann; Lisa K Perriera; Matthew Reeves; Beatrice A Chen; Jennifer L Hayes; Mitchell Creinin
Immediate versus delayed insertion of the levonorgestrel-releasing intrauterine device following dilation and evacuation: a randomized controlled trial.
Contraception 2012;85(3):240-5.
2011: Leah C Wilson; Leslie A Meyn; Mitchell Creinin
Cervical preparation for surgical abortion between 12 and 18 weeks of gestation using vaginal misoprostol and Dilapan-S.
Contraception 2011;83(6):511-6.
2011: Kathleen M Kollitz; Patricia A Lohr; Leslie A Meyn; Mitchell Creinin
Mifepristone and misoprostol for early pregnancy failure: a cohort analysis.
American journal of obstetrics and gynecology 2011;204(5):386.e1-6.
2011: Sonya Borrero; Kaleab Abebe; Christine Dehlendorf; Eleanor Bimla Schwarz; Mitchell Creinin; Cara Nikolajski; Said Ibrahim
Racial variation in tubal sterilization rates: role of patient-level factors.
Fertility and sterility 2011;95(1):17-22.
2010: Beatrice A Chen; Matthew Reeves; Jennifer L Hayes; Heather L Hohmann; Lisa K Perriera; Mitchell Creinin
Postplacental or delayed insertion of the levonorgestrel intrauterine device after vaginal delivery: a randomized controlled trial.
Obstetrics and gynecology 2010;116(5):1079-87.
2010: J A Russo; Mitchell Creinin
Ulipristal acetate for emergency contraception.
Drugs of today (Barcelona, Spain : 1998) 2010;46(9):655-60.
2010: Christina M Racek; Beatrice A Chen; Mitchell Creinin
Complication rates and utility of intravenous access for surgical abortion procedures from 12 to 18 weeks of gestation.
Contraception 2010;82(3):286-90.
2010: Sonya Borrero; Charity G Moore; Mitchell Creinin; Said A Ibrahim
Low rates of vasectomy among minorities: a result of differential receipt of counseling?
American journal of men's health 2010;4(3):243-9.
2010: Amy K Whitaker; Mishka Terplan; Melanie A Gold; Lisa M Johnson; Mitchell Creinin; Bryna Harwood
Effect of a brief educational intervention on the attitudes of young women toward the intrauterine device.
Journal of pediatric and adolescent gynecology 2010;23(2):116-20.
2010: Lisa K Perriera; Matthew Reeves; Beatrice A Chen; Heather L Hohmann; Jennifer Hayes; Mitchell Creinin
Feasibility of telephone follow-up after medical abortion.
Contraception 2010;81(2):143-9.
2010: Sonya Borrero; Charity G Moore; Li Qin; Eleanor Bimla Schwarz; Aletha Akers; Mitchell Creinin; Said A Ibrahim
Unintended pregnancy influences racial disparity in tubal sterilization rates.
Journal of general internal medicine 2010;25(2):122-8.
2010: Clarisa R Gracia; Mary D Sammel; Sarah Charlesworth; Hui Lin; Kurt T Barnhart; Mitchell Creinin
Sexual function in first-time contraceptive ring and contraceptive patch users.
Fertility and sterility 2010;93(1):21-8.
2009: Carolyn B Sufrin; Mitchell Creinin; Judy C Chang
Contraception services for incarcerated women: a national survey of correctional health providers.
Contraception 2009;80(6):561-5.
2009: Heather Hohmann; Lynn Reid; Mitchell Creinin
Women's motivation to participate in contraceptive efficacy trials.
Contraception 2009;80(3):270-5.
2009: Matthew Reeves; Michelle Candice Fox; Patricia A Lohr; Mitchell Creinin
Endometrial thickness following medical abortion is not predictive of subsequent surgical intervention.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2009;34(1):104-9.
2009: Sonya Borrero; Eleanor Bimla Schwarz; Matthew Reeves; James E Bost; Mitchell Creinin; Said A Ibrahim
Does vasectomy explain the difference in tubal sterilization rates between black and white women?
Fertility and sterility 2009;91(5):1642-5.
2009: Eleanor Bimla Schwarz; Megan Kavanaugh; Erika Douglas; Tamara Dubowitz; Mitchell Creinin
Interest in intrauterine contraception among seekers of emergency contraception and pregnancy testing.
Obstetrics and gynecology 2009;113(4):833-9.
2009: Mitchell Creinin; Hyagriv N Simhan
Can we communicate gravidity and parity better?
Obstetrics and gynecology 2009;113(3):709-11.
2009: Carolyn B Sufrin; Mitchell Creinin; Judy C Chang
Incarcerated women and abortion provision: a survey of correctional health providers.
Perspectives on sexual and reproductive health 2009;41(1):6-11.
2009: Sonya Borrero; Cara Nikolajski; Keri L Rodriguez; Mitchell Creinin; Robert M Arnold; Said A Ibrahim
"Everything I know I learned from my mother...Or not": perspectives of African-American and white women on decisions about tubal sterilization.
Journal of general internal medicine 2009;24(3):312-9.
2009: Deborah J Anderson; D'Nyce L Williams; Susan A Ballagh; Kurt Barnhart; Mitchell Creinin; Daniel R Newman; Frederick P Bowman; Joseph A Politch; Ann C Duerr; Denise J Jamieson
Safety analysis of the diaphragm in combination with lubricant or acidifying microbicide gels: effects on markers of inflammation and innate immunity in cervicovaginal fluid.
American journal of reproductive immunology (New York, N.Y. : 1989) 2009;61(2):121-9.
2009: Matthew Reeves; Patricia A Lohr; Jennifer L Hayes; Bryna Harwood; Mitchell Creinin
Doxycycline serum levels at the time of dilation and evacuation with two dosing regimens.
Contraception 2009;79(2):129-33.
2009: Leah C Wilson; Beatrice A Chen; Mitchell Creinin
Low-dose fentanyl and midazolam in outpatient surgical abortion up to 18 weeks of gestation.
Contraception 2009;79(2):122-8.
2009: Sonya Borrero; Eleanor Bimla Schwarz; Mitchell Creinin; Said A Ibrahim
The impact of race and ethnicity on receipt of family planning services in the United States.
Journal of women's health (2002) 2009;18(1):91-6.
2008: Beverly Winikoff; Ilana G Dzuba; Mitchell Creinin; William A Crowden; Alisa B Goldberg; Juliana Gonzales; Michelle Howe; Jeffrey Moskowitz; Linda Prine; Caitlin Spencer Shannon
Two distinct oral routes of misoprostol in mifepristone medical abortion: a randomized controlled trial.
Obstetrics and gynecology 2008;112(6):1303-10.
2008: Jill L Schwartz; Kurt Barnhart; Mitchell Creinin; Alfred Poindexter; Angie Wheeless; Maggie Kilbourne-Brook; Christine K Mauck; Debra H Weiner; Marianne M Callahan
Comparative crossover study of the PATH Woman's Condom and the FC Female Condom.
Contraception 2008;78(6):465-73.
2008: Christine K Mauck; Susan A Ballagh; Mitchell Creinin; Debra H Weiner; Gustavo F Doncel; Raina N Fichorova; Jill L Schwartz; Neelima Chandra; Marianne M Callahan
Six-day randomized safety trial of intravaginal lime juice.
Journal of acquired immune deficiency syndromes (1999) 2008;49(3):243-50.
2008: Matthew Reeves; Anupa Kudva; Mitchell Creinin
Medical abortion outcomes after a second dose of misoprostol for persistent gestational sac.
Contraception 2008;78(4):332-5.
2008: Beatrice A Chen; Mitchell Creinin
Medical management of early pregnancy failure: efficacy.
Seminars in reproductive medicine 2008;26(5):411-22.
2008: Jill L Schwartz; Susan A Ballagh; Mitchell Creinin; Robert W Rountree; Maggie Kilbourne-Brook; Christine K Mauck; Marianne M Callahan
SILCS diaphragm: postcoital testing of a new single-size contraceptive device.
Contraception 2008;78(3):237-44.
2008: Amy K Whitaker; Lisa M Johnson; Bryna Harwood; Laurel Chiappetta; Mitchell Creinin; Melanie A Gold
Adolescent and young adult women's knowledge of and attitudes toward the intrauterine device.
Contraception 2008;78(3):211-7.
2008: Erica O'Neill; Matthew Reeves; Mitchell Creinin
Baseline colposcopic findings in women entering studies on female vaginal products.
Contraception 2008;78(2):162-6.
2008: Sonya B Borrero; Matthew Reeves; Eleanor Bimla Schwarz; James E Bost; Mitchell Creinin; Said A Ibrahim
Race, insurance status, and desire for tubal sterilization reversal.
Fertility and sterility 2008;90(2):272-7.
2008: Sofia Kazi; Matthew Reeves; Mitchell Creinin
The prevalence of domestic violence in volunteers for abortion and contraceptive research studies.
Contraception 2008;78(1):79-83.
2008: Paula Bednarek; Mark D Nichols; Nichole E Carlson; Alison Edelman; Mitchell Creinin; Sarah Truitt; Jeffrey Jensen
Effect of "observed start" vs. traditional "Sunday start" on hormonal contraceptive continuation rates after medical abortion.
Contraception 2008;78(1):26-30.
2008: Beatrice A Chen; Matthew Reeves; Mitchell Creinin; Jerry M Gilles; Kurt Barnhart; Carolyn Westhoff; Jun Zhang
Misoprostol for treatment of early pregnancy failure in women with previous uterine surgery.
American journal of obstetrics and gynecology 2008;198(6):626.e1-5.
2008: Mitchell Creinin; Leslie A Meyn; Lynn Borgatta; Kurt Barnhart; Jeffrey Jensen; Anne E Burke; Carolyn Westhoff; Melissa Gilliam; Caryn Dutton; Susan A Ballagh
Multicenter comparison of the contraceptive ring and patch: a randomized controlled trial.
Obstetrics and gynecology 2008;111(2 Pt 1):267-77.
2008: Bryna Harwood; Leslie A Meyn; Susan A Ballagh; Elizabeth G Raymond; David F Archer; Mitchell Creinin
Cervicovaginal colposcopic lesions associated with 5 nonoxynol-9 vaginal spermicide formulations.
American journal of obstetrics and gynecology 2008;198(1):32.e1-7.
2008: Matthew Reeves; Patricia A Lohr; Bryna Harwood; Mitchell Creinin
Ultrasonographic endometrial thickness after medical and surgical management of early pregnancy failure.
Obstetrics and gynecology 2008;111(1):106-12.
2007: D'Nyce L Williams; Daniel R Newman; Susan A Ballagh; Mitchell Creinin; Kurt Barnhart; Debra H Weiner; April J Bell; Denise J Jamieson
Phase I safety trial of two vaginal microbicide gels (Acidform or BufferGel) used with a diaphragm compared to KY jelly used with a diaphragm.
Sexually transmitted diseases 2007;34(12):977-84.
2007: Heather Hohmann; Mitchell Creinin
The contraceptive implant.
Clinical obstetrics and gynecology 2007;50(4):907-17.
2007: Elisa S Wells; Mitchell Creinin; Pablo Rodríguez
From American Idol to Plan B: a call for a shift in priorities.
Contraception 2007;76(5):337-8.
2007: C Robledo; Jun Zhang; James F Troendle; Kurt Barnhart; Mitchell Creinin; Carolyn Westhoff; X Huang; M Frederick
Clinical indicators for success of misoprostol treatment after early pregnancy failure.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2007;99(1):46-51.
2007: Kurt T Barnhart; Michael J Rosenberg; Hugh Trent Mackay; Diana L Blithe; Jim Higgins; Terri Walsh; Livia Wan; Michael A Thomas; Mitchell Creinin; Carolyn Westhoff; William D Schlaff; David F Archer; Charletta Ayers; Andrew Kaunitz; Sutapa Das; Thomas R Moench
Contraceptive efficacy of a novel spermicidal microbicide used with a diaphragm: a randomized controlled trial.
Obstetrics and gynecology 2007;110(3):577-86.
2007: Patricia A Lohr; Matthew Reeves; Jennifer L Hayes; Bryna Harwood; Mitchell Creinin
Oral mifepristone and buccal misoprostol administered simultaneously for abortion: a pilot study.
Contraception 2007;76(3):215-20.
2007: David N Hackney; Mitchell Creinin; Hyagriv N Simhan
Medical management of early pregnancy failure in a patient with coronary artery disease.
Fertility and sterility 2007;88(1):212.e1-3.
2007: Matthew Reeves; Kenneth J Smith; Mitchell Creinin
Contraceptive effectiveness of immediate compared with delayed insertion of intrauterine devices after abortion: a decision analysis.
Obstetrics and gynecology 2007;109(6):1286-94.
2007: Emily M Godfrey; Anita Anderson; Stephen L Fielding; Leslie Meyn; Mitchell Creinin
Clinical utility of urine pregnancy assays to determine medical abortion outcome is limited.
Contraception 2007;75(5):378-82.
2007: Mitchell Creinin; Courtney A Schreiber; Paula Bednarek; Hanna Lintu; Marie-Soleil Wagner; Leslie A Meyn
Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trial.
Obstetrics and gynecology 2007;109(4):885-94.
2007: Beatrice A Chen; Mitchell Creinin
Contemporary management of early pregnancy failure.
Clinical obstetrics and gynecology 2007;50(1):67-88.
2007: Dorothy Sit; Anthony J Rothschild; Mitchell Creinin; Barbara H Hanusa; Katherine L Wisner
Psychiatric outcomes following medical and surgical abortion.
Human reproduction (Oxford, England) 2007;22(3):878-84.
2007: Craig A H Richard; Mitchell Creinin; Carolyn J Kubik; Julie A DeLoia
Enzymatic removal of asparagine-linked carbohydrate chains from heterodimer human chorionic gonadotrophin and effect on bioactivity.
Reproduction, fertility, and development 2007;19(8):933-46.
2007: Anne R Davis; Sarah K Hendlish; Carolyn Westhoff; Margaret M Frederick; Jun Zhang; Jerry M Gilles; Kurt Barnhart; Mitchell Creinin
Bleeding patterns after misoprostol vs surgical treatment of early pregnancy failure: results from a randomized trial.
American journal of obstetrics and gynecology 2007;196(1):31.e1-7.
2007: Sonya Borrero; Eleanor Bimla Schwarz; Matthew Reeves; James E Bost; Mitchell Creinin; Said A Ibrahim
Race, insurance status, and tubal sterilization.
Obstetrics and gynecology 2007;109(1):94-100.
2006: Courtney A Schreiber; Mitchell Creinin; Matthew Reeves; Bryna Harwood
Mifepristone and misoprostol for the treatment of early pregnancy failure: a pilot clinical trial.
Contraception 2006;74(6):458-62.
2006: Mitchell Creinin; William D Schlaff; David F Archer; Livia Wan; Ron Frezieres; Michael A Thomas; Michael Rosenberg; James Higgins
Progesterone receptor modulator for emergency contraception: a randomized controlled trial.
Obstetrics and gynecology 2006;108(5):1089-97.
2006: Patricia A Lohr; Mitchell Creinin
Oral contraceptives and breakthrough bleeding: what patients need to know.
The Journal of family practice 2006;55(10):872-80.
2006: Jill L Schwartz; Christine K Mauck; Jaim-Jou Lai; Mitchell Creinin; Vivian Brache; Susan A Ballagh; Debra H Weiner; Sharon L Hillier; Raina N Fichorova; Marianne Callahan
Fourteen-day safety and acceptability study of 6% cellulose sulfate gel: a randomized double-blind Phase I safety study.
Contraception 2006;74(2):133-40.
2006: Mitchell Creinin
SOGC clinical practice guidelines: ultrasound evaluation of first trimester pregnancy complications.
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstétrique et gynécologie du Canada : JOGC 2006;28(7):581; author reply 582.
2006: Mitchell Creinin
Early abortion in Ontario: options and costs.
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstétrique et gynécologie du Canada : JOGC 2006;28(6):504; author reply 504.
2006: Courtney A Schreiber; Bryna Harwood; Galen E Switzer; Mitchell Creinin; Matthew Reeves; Roberta B Ness
Training and attitudes about contraceptive management across primary care specialties: a survey of graduating residents.
Contraception 2006;73(6):618-22.
2006: Lee P Shulman; Louise H Bateman; Mitchell Creinin; Vanessa E Cullins; Lee Lee Doyle; Emily M Godfrey; Patricia Murphy; Pablo Rodriguez; Scott J Spear; Felicia H Stewart; Michael A Thomas; Carolyn L Westhoff; Sandra Worthington
Surrogate markers, emboldened and boxed warnings, and an expanding culture of misinformation: evidence-based clinical science should guide FDA decision making about product labeling.
Contraception 2006;73(5):440-2.
2006: Mitchell Creinin; Xiangke Huang; Carolyn Westhoff; Kurt Barnhart; Jerry M Gilles; Jun Zhang
Factors related to successful misoprostol treatment for early pregnancy failure.
Obstetrics and gynecology 2006;107(4):901-7.
2006: Mitchell Creinin; Paul Blumenthal; Lee Shulman
Mortality associated with mifepristone-misoprostol medical abortion.
MedGenMed : Medscape general medicine 2006;8(2):26.
2006: Courtney A Schreiber; Leslie A Meyn; Mitchell Creinin; Kurt T Barnhart; Sharon L Hillier
Effects of long-term use of nonoxynol-9 on vaginal flora.
Obstetrics and gynecology 2006;107(1):136-43.
2006: Christine K Mauck; Debra H Weiner; Mitchell Creinin; David F Archer; Jill L Schwartz; Helen C Pymar; Susan A Ballagh; Deborah M Henry; Marianne M Callahan
FemCap with removal strap: ease of removal, safety and acceptability.
Contraception 2006;73(1):59-64.
2005: Amitasrigowri Murthy; Mitchell Creinin; Bryna Harwood; Courtney A Schreiber
Same-day initiation of the transdermal hormonal delivery system (contraceptive patch) versus traditional initiation methods.
Contraception 2005;72(5):333-6.
2005: Jun Zhang; Jerry M Gilles; Kurt Barnhart; Mitchell Creinin; Carolyn Westhoff; Margaret M Frederick
A comparison of medical management with misoprostol and surgical management for early pregnancy failure.
The New England journal of medicine 2005;353(8):761-9.
2005: Matthew Reeves; Bryna Harwood; Mitchell Creinin
The challenges of analyzing cost-effectiveness with a computer model.
Fertility and sterility 2005;84(2):543; author reply 543-4.
2005: Mitchell Creinin; Wayne Shields
How do we ensure 'high quality' clinical research?
Contraception 2005;72(2):83-4.
2005: Christine K Mauck; Mitchell Creinin; Wes Rountree; Marianne M Callahan; Sharon L Hillier
Lea's Shield: colposcopic and microbiological testing during 8 weeks of use.
Contraception 2005;72(1):53-9.
2005: Mitchell Creinin; Elizabeth Roberts
Body mass index, weight, and oral contraceptive failure risk.
Obstetrics and gynecology 2005;105(6):1492; author reply1492-3.
2005: Courtney A Schreiber; Mitchell Creinin; Bryna Harwood; Amitasrigowri Murthy
A pilot study of mifepristone and misoprostol administered at the same time for abortion in women with gestation from 50 to 63 days.
Contraception 2005;71(6):447-50.
2005: Elizabeth G Raymond; Pai-Lien Chen; Sean Condon; Joanne Luoto; Kurt T Barnhart; Mitchell Creinin; Alfred Poindexter; Livia Wan; Mark Martens; Robert Schenken; Richard Blackwell
Acceptability of five nonoxynol-9 spermicides.
Contraception 2005;71(6):438-42.
2005: Amitasrigowri Murthy; Mitchell Creinin; Bryna Harwood; Courtney A Schreiber
A pilot study of mifepristone and misoprostol administered at the same time for abortion up to 49 days gestation.
Contraception 2005;71(5):333-6.
2005: Courtney A Schreiber; Mitchell Creinin
Mifepristone in abortion care.
Seminars in reproductive medicine 2005;23(1):82-91.
2005: Mitchell Creinin; Eliane Shore; Shyamala Balasubramanian; Bryna Harwood
The true cost differential between mifepristone and misoprostol and misoprostol-alone regimens for medical abortion.
Contraception 2005;71(1):26-30.
2004: Elizabeth G Raymond; Pai-Lien Chen; Bosny Pierre-Louis; Joanne Luoto; Kurt T Barnhart; Lynn Bradley; Mitchell Creinin; Alfred Poindexter; Livia Wan; Mark Martens; Robert Schenken; Cate F Nicholas; Richard Blackwell
Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectiveness.
BMC medical research methodology 2004;4():23.
2004: Brooke Rossi; Mitchell Creinin; Leslie A Meyn
Ability of the clinician and patient to predict the outcome of mifepristone and misoprostol medical abortion.
Contraception 2004;70(4):313-7.
2004: Mitchell Creinin; Sharon Keverline; Leslie A Meyn
How regular is regular? An analysis of menstrual cycle regularity.
Contraception 2004;70(4):289-92.
2004: Christine K Mauck; Debra H Weiner; Mitchell Creinin; Kurt T Barnhart; Marianne M Callahan; Richard Bax
A randomized Phase I vaginal safety study of three concentrations of C31G vs. Extra Strength Gynol II.
Contraception 2004;70(3):233-40.
2004: Christine K Mauck; Mitchell Creinin; Kurt T Barnhart; Susan A Ballagh; David F Archer; Marianne M Callahan; Susan W Schmitz; Richard Bax
A phase I comparative postcoital testing study of three concentrations of C31G.
Contraception 2004;70(3):227-31.
2004: Christine K Mauck; Debra H Weiner; Susan A Ballagh; Mitchell Creinin; David F Archer; Jill L Schwartz; Helen C Pymar; Jaim-Jou Lai; William F Rencher; Marianne M Callahan
Single and multiple exposure tolerance study of polystyrene sulfonate gel: a phase I safety and colposcopy study.
Contraception 2004;70(1):77-83.
2004: Mitchell Creinin; Bryna Harwood; Richard S Guido; Michelle Candice Fox; Jun Zhang
Endometrial thickness after misoprostol use for early pregnancy failure.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2004;86(1):22-6.
2004: Mitchell Creinin; Michelle Candice Fox; Stephanie Teal; Angela Chen; Eric A Schaff; Leslie A Meyn
A randomized comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortion.
Obstetrics and gynecology 2004;103(5 Pt 1):851-9.
2004: David Grimes; Mitchell Creinin
Induced abortion: an overview for internists.
Annals of internal medicine 2004;140(8):620-6.
2004: Jerry M Gilles; Mitchell Creinin; Kurt Barnhart; Carolyn Westhoff; Margaret M Frederick; Jun Zhang
A randomized trial of saline solution-moistened misoprostol versus dry misoprostol for first-trimester pregnancy failure.
American journal of obstetrics and gynecology 2004;190(2):389-94.
2004: Barry K Ray; Manuel C Vallejo; Mitchell Creinin; Kelly T Shannon; Gordon L Mandell; Bupesh Kaul; Sivam Ramanathan
Amniotic fluid embolism with second trimester pregnancy termination: a case report.
Canadian journal of anaesthesia = Journal canadien d'anesthésie 2004;51(2):139-44.
2004: Helen C Pymar; Mitchell Creinin; Manuel C Vallejo
Prospective randomized, controlled study of postoperative pain after titanium silicone rubber clip or Silastic ring tubal occlusion.
Contraception 2004;69(2):145-50.
2003: Mitchell Creinin
Current medical abortion care.
Current women's health reports 2003;3(6):461-9.
2003: Jennifer N Isaacs; Mitchell Creinin
Miscommunication between healthcare providers and patients may result in unplanned pregnancies.
Contraception 2003;68(5):373-6.
2003: Michelle Candice Fox; Mitchell Creinin; Amitasrigowri Murthy; Bryna Harwood; Lynn M Reid
Feasibility study of the use of a daily electronic mail reminder to improve oral contraceptive compliance.
Contraception 2003;68(5):365-71.
2003: Amitasrigowri Murthy; Mitchell Creinin
Pharmacoeconomics of medical abortion: a review of cost in the United States, Europe and Asia.
Expert opinion on pharmacotherapy 2003;4(4):503-13.
2003: Mitchell Creinin; Cynthia Potter; Maria Holovanisin; Lynn Janczukiewicz; Helen C Pymar; Jill L Schwartz; Leslie A Meyn
Mifepristone and misoprostol and methotrexate/misoprostol in clinical practice for abortion.
American journal of obstetrics and gynecology 2003;188(3):664-9.
2002: Michelle Candice Fox; Mitchell Creinin; Bryna Harwood
Mifepristone and vaginal misoprostol on the same day for abortion from 50 to 63 days' gestation.
Contraception 2002;66(4):225-9.
2002: Mitchell Creinin; Joel S Lippman; Scott E Eder; Amy J Godwin; William Olson
The effect of extending the pill-free interval on follicular activity: triphasic norgestimate/35 micro g ethinyl estradiol versus monophasic levonorgestrel/20 micro g ethinyl estradiol.
Contraception 2002;66(3):147-52.
2002: Mitchell Creinin; Bryna Harwood; Richard S Guido
Medical management of missed abortion: a randomized clinical trial.
Obstetrics and gynecology 2002;100(2):382-3.
2002: Pablo Uribasterra; Mitchell Creinin; Harold C Wiesenfeld
Does digital vaginal examination using lubricant have an impact on testing for Chlamydia trachomatis by polymerase chain reaction?
Sexually transmitted diseases 2002;29(2):112-3.
2002: Jill L Schwartz; Mitchell Creinin; Helen C Pymar; Lynn Reid
Predicting risk of ovulation in new start oral contraceptive users.
Obstetrics and gynecology 2002;99(2):177-82.
2001: Christine K Mauck; Debra H Weiner; Susan A Ballagh; Mitchell Creinin; David F Archer; J Schwartz; Helen C Pymar; Jaim-Jou Lai; Marianne Callahan
Single and multiple exposure tolerance study of cellulose sulfate gel: a Phase I safety and colposcopy study.
Contraception 2001;64(6):383-91.
2001: Helen C Pymar; Mitchell Creinin
The risks of oral contraceptive pills.
Seminars in reproductive medicine 2001;19(4):305-12.
2001: G Sutkin; S D Capelle; P M Schlievert; Mitchell Creinin
Toxic shock syndrome after laminaria insertion.
Obstetrics and gynecology 2001;98(5 Pt 2):959-61.
2001: Mitchell Creinin; Leslie A Meyn; T Klimashko
Accuracy of serum beta-human chorionic gonadotropin cutoff values at 42 and 49 days' gestation.
American journal of obstetrics and gynecology 2001;185(4):966-9.
2001: Mitchell Creinin; Helen C Pymar; Jill L Schwartz
Mifepristone 100 mg in abortion regimens.
Obstetrics and gynecology 2001;98(3):434-9.
2001: Helen C Pymar; Mitchell Creinin; Jill L Schwartz
Mifepristone followed on the same day by vaginal misoprostol for early abortion.
Contraception 2001;64(2):87-92.
2001: Mitchell Creinin; Jill L Schwartz; Helen C Pymar; W Fink
Efficacy of mifepristone followed on the same day by misoprostol for early termination of pregnancy: report of a randomised trial.
BJOG : an international journal of obstetrics and gynaecology 2001;108(5):469-73.
2001: Mitchell Creinin; Jill L Schwartz; Richard S Guido; Helen C Pymar
Early pregnancy failure--current management concepts.
Obstetrical & gynecological survey 2001;56(2):105-13.
2000: Mitchell Creinin
Randomized comparison of efficacy, acceptability and cost of medical versus surgical abortion.
Contraception 2000;62(3):117-24.
2000: B Kruse; S Poppema; Mitchell Creinin; M Paul
Management of side effects and complications in medical abortion.
American journal of obstetrics and gynecology 2000;183(2 Suppl):S65-75.
2000: Helen C Pymar; Mitchell Creinin
Alternatives to mifepristone regimens for medical abortion.
American journal of obstetrics and gynecology 2000;183(2 Suppl):S54-64.
2000: Mitchell Creinin
Medical abortion regimens: historical context and overview.
American journal of obstetrics and gynecology 2000;183(2 Suppl):S3-9.
2000: E G Raymond; Mitchell Creinin; Kurt T Barnhart; A E Lovvorn; R W Rountree; J Trussell
Meclizine for prevention of nausea associated with use of emergency contraceptive pills: a randomized trial.
Obstetrics and gynecology 2000;95(2):271-7.
2000: Mitchell Creinin; Helen C Pymar
Medical abortion alternatives to mifepristone.
Journal of the American Medical Women's Association (1972) 2000;55(3 Suppl):127-32, 150.
2000: James G Kahn; B J Becker; L MacIsaa; J K Amory; J Neuhaus; I Olkin; Mitchell Creinin
The efficacy of medical abortion: a meta-analysis.
Contraception 2000;61(1):29-40.
1999: Mitchell Creinin; I M Spitz
Use of various ultrasonographic criteria to evaluate the efficacy of mifepristone and misoprostol for medical abortion.
American journal of obstetrics and gynecology 1999;181(6):1419-24.
1999: Jill L Schwartz; Mitchell Creinin; Helen C Pymar
The trimonthly combination oral contraceptive regimen: is it cost effective?
Contraception 1999;60(5):263-7.
1999: Mitchell Creinin; R Lisman; R C Strickler
Screening for factor V Leiden mutation before prescribing combination oral contraceptives.
Fertility and sterility 1999;72(4):646-51.
1999: Helen C Pymar; Mitchell Creinin; Jill L Schwartz
"Pop-out" method of levonorgestrel implant removal.
Contraception 1999;59(6):383-7.
1999: Mitchell Creinin
Conception rates after abortion with methotrexate and misoprostol.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 1999;65(2):183-8.
1999: Mitchell Creinin; E Wiebe; M Gold
Methotrexate and misoprostol for early abortion in adolescent women.
Journal of pediatric and adolescent gynecology 1999;12(2):71-7.
1999: Mitchell Creinin; J L L Carbonell; Jill L Schwartz; Lidia Varela; R Tanda
A randomized trial of the effect of moistening misoprostol before vaginal administration when used with methotrexate for abortion.
Contraception 1999;59(1):11-6.
1999: Mitchell Creinin; H Jerald
Success rates and estimation of gestational age for medical abortion vary with transvaginal ultrasonographic criteria.
American journal of obstetrics and gynecology 1999;180(1 Pt 1):35-41.
1998: Mitchell Creinin
Delayed retained products of conception after second-trimester abortion.
Obstetrics and gynecology 1998;92(4 Pt 2):710.
1998: Mitchell Creinin; Ann M Stewart-Akers; Julie A DeLoia
Methotrexate effects on trophoblast and the corpus luteum in early pregnancy.
American journal of obstetrics and gynecology 1998;179(3 Pt 1):604-9.
1998: Julie A DeLoia; Ann M Stewart-Akers; Mitchell Creinin
Effects of methotrexate on trophoblast proliferation and local immune responses.
Human reproduction (Oxford, England) 1998;13(4):1063-9.
1998: Mitchell Creinin
Evaluation of postmenopausal bleeding.
American journal of obstetrics and gynecology 1998;178(4):868-70.
1997: Mitchell Creinin
Medical abortion with methotrexate 75 mg intramuscularly and vaginal misoprostol.
Contraception 1997;56(6):367-71.
1997: Mitchell Creinin; Marijane A Krohn
Methotrexate pharmacokinetics and effects in women receiving methotrexate 50 mg and 60 mg per square meter for early abortion.
American journal of obstetrics and gynecology 1997;177(6):1444-9.
1997: Mitchell Creinin; Eric Vittinghoff; E Schaff; C Klaisle; Philip D Darney; C Dean
Medical abortion with oral methotrexate and vaginal misoprostol.
Obstetrics and gynecology 1997;90(4 Pt 1):611-6.
1997: L D Thoen; Mitchell Creinin
Medical treatment of ectopic pregnancy with methotrexate.
Fertility and sterility 1997;68(4):727-30.
1997: Mitchell Creinin; T Shulman
Effect of nonsteroidal anti-inflammatory drugs on the action of misoprostol in a regimen for early abortion.
Contraception 1997;56(3):165-8.
1997: Mitchell Creinin; R Moyer; Richard S Guido
Misoprostol for medical evacuation of early pregnancy failure.
Obstetrics and gynecology 1997;89(5 Pt 1):768-72.
1997: Mitchell Creinin
Laparoscopic salpingostomy versus methotrexate injections.
American journal of obstetrics and gynecology 1997;176(4):949; author reply 949-50.
1997: Mitchell Creinin
A reassessment of efficacy of the Yuzpe regimen of emergency contraception.
Human reproduction (Oxford, England) 1997;12(3):496-8.
1996: Mitchell Creinin
Medically induced abortion in a woman with a large myomatous uterus.
American journal of obstetrics and gynecology 1996;175(5):1379-80.
1996: Mitchell Creinin; A E Burke
Methotrexate and misoprostol for early abortion: a multicenter trial. Acceptability.
Contraception 1996;54(1):19-22.
1996: Mitchell Creinin
Oral methotrexate and vaginal misoprostol for early abortion.
Contraception 1996;54(1):15-8.
1996: Mitchell Creinin
Laboratory criteria for menopause in women using oral contraceptives.
Fertility and sterility 1996;66(1):101-4.
1996: Mitchell Creinin; Eric Vittinghoff; L Keder; Philip D Darney; G Tiller
Methotrexate and misoprostol for early abortion: a multicenter trial. I. Safety and efficacy.
Contraception 1996;53(6):321-7.
1996: Mitchell Creinin
Change in serum beta-human chorionic gonadotropin after abortion with methotrexate and misoprostol.
American journal of obstetrics and gynecology 1996;174(2):776-8.
1995: Mitchell Creinin; Eric Vittinghoff; S Galbraith; C Klaisle
A randomized trial comparing misoprostol three and seven days after methotrexate for early abortion.
American journal of obstetrics and gynecology 1995;173(5):1578-84.
1995: Mitchell Creinin; C M Klaisle
Removal of levonorgestrel capsules from the biceps muscle.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 1995;50(2):189-91.
1995: Mitchell Creinin; M Park
Acceptability of medical abortion with methotrexate and misoprostol.
Contraception 1995;52(1):41-4.
1995: Mitchell Creinin; Vickie A Feldstein
Conservative management options for cervical pregnancy; case reports and literature review.
International journal of fertility and menopausal studies 1995;40(4):175-86.
1995: Mitchell Creinin
Laminaria versus Dilapan osmotic cervical dilators for second-trimester abortion.
American journal of obstetrics and gynecology 1995;173(1):354-5.
1994: Mitchell Creinin
Methotrexate and misoprostol for abortion at 57-63 days gestation.
Contraception 1994;50(6):511-5.
1994: Mitchell Creinin; Eric Vittinghoff
Methotrexate and misoprostol vs misoprostol alone for early abortion. A randomized controlled trial.
JAMA : the journal of the American Medical Association 1994;272(15):1190-5.
1993: Mitchell Creinin; A Eugene Washington
Cost of ectopic pregnancy management: surgery versus methotrexate.
Fertility and sterility 1993;60(6):963-9.
1993: Mitchell Creinin
Methotrexate for abortion at < or = 42 days gestation.
Contraception 1993;48(6):519-25.
1993: Mitchell Creinin; Philip D Darney
Methotrexate and misoprostol for early abortion.
Contraception 1993;48(4):339-48.
1992: Mitchell Creinin; M Chen
Uterine defect in a twin pregnancy with a history of hysteroscopic fundal perforation.
Obstetrics and gynecology 1992;79(5 ( Pt 2)):879-80.
1991: Mitchell Creinin; M Katz; Russell K Laros
Triplet pregnancy: changes in morbidity and mortality.
Journal of perinatology : official journal of the California Perinatal Association 1991;11(3):207-12.
1990: M M Miller; D I Hoffman; Mitchell Creinin; J H Levin; Robert T Chatterton; T Murad; R W Rebar
Comparison of endometrial biopsy and urinary pregnanediol glucuronide concentration in the diagnosis of luteal phase defect.
Fertility and sterility 1990;54(6):1008-11.
1989: Mitchell Creinin; Louis G Keith
The Yoruba contribution to our understanding of the twinning process.
The Journal of reproductive medicine 1989;34(6):379-87.
1989: Louis G Keith; Mitchell Creinin; M W Method; D Hidvegi
Cervicitis as an antecedent to pelvic infection: a review.
International journal of fertility 1989;34(2):109-19.
1988: Mitchell Creinin; S MacGregor; M Socol; J Hobart; S Ameli; Louis G Keith
The Northwestern University triplet study. IV. Biochemical parameters.
American journal of obstetrics and gynecology 1988;159(5):1140-3.